Lin Zhou

12.5k total citations · 3 hit papers
300 papers, 9.2k citations indexed

About

Lin Zhou is a scholar working on Molecular Biology, Hepatology and Epidemiology. According to data from OpenAlex, Lin Zhou has authored 300 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Molecular Biology, 84 papers in Hepatology and 77 papers in Epidemiology. Recurrent topics in Lin Zhou's work include Organ Transplantation Techniques and Outcomes (50 papers), Liver Disease and Transplantation (44 papers) and Liver Disease Diagnosis and Treatment (41 papers). Lin Zhou is often cited by papers focused on Organ Transplantation Techniques and Outcomes (50 papers), Liver Disease and Transplantation (44 papers) and Liver Disease Diagnosis and Treatment (41 papers). Lin Zhou collaborates with scholars based in China, Madagascar and United States. Lin Zhou's co-authors include Shusen Zheng, Haiyang Xie, Jian Wu, Xiao Xu, Shengyong Yin, Shusen Zheng, Jiacheng Huang, Yiting Qiao, Shengzhang Lin and Dalong Wan and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Lin Zhou

289 papers receiving 9.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Extracellular matrix and its therapeutic potential for cancer treatment

2021 580 citations Jiacheng Huang, Dalong Wan et al. profile →
Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma

2018 543 citations Zhigang Ren, Jianwen Jiang et al. profile →
WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1

2019 479 citations Junru Chen, Haiyang Xie et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lin Zhou China	47	4.6k	2.0k	1.9k	1.5k	1.5k	300	9.2k
Xiao Xu China	48	3.8k 0.8×	1.7k 0.9×	1.5k 0.8×	1.4k 1.0×	1.6k 1.1×	354	8.5k
Hirohisa Yano Japan	43	3.1k 0.7×	2.4k 1.2×	1.7k 0.9×	1.0k 0.7×	1.5k 1.1×	283	8.0k
Grietje Molema Netherlands	56	4.9k 1.0×	1.3k 0.6×	1.2k 0.6×	1.2k 0.8×	1.0k 0.7×	229	10.3k
Haiyang Xie China	58	8.1k 1.8×	3.2k 1.6×	4.6k 2.4×	2.0k 1.4×	2.0k 1.4×	449	14.9k
Hongming Pan China	46	3.8k 0.8×	3.1k 1.5×	1.8k 0.9×	2.3k 1.5×	819 0.6×	222	9.2k
Edward K. Geissler Germany	53	3.7k 0.8×	2.6k 1.3×	1.0k 0.5×	1.0k 0.7×	2.5k 1.7×	263	10.4k
Toshiyoshi Fujiwara Japan	58	5.9k 1.3×	5.1k 2.5×	2.1k 1.1×	812 0.6×	2.3k 1.5×	610	13.3k
Georg Feldmann Germany	41	5.6k 1.2×	3.2k 1.6×	2.7k 1.4×	738 0.5×	993 0.7×	134	10.3k
Kwan Man Hong Kong	53	3.2k 0.7×	1.5k 0.7×	1.6k 0.8×	1.8k 1.2×	1.4k 1.0×	176	7.7k
Hirofumi Yamamoto Japan	61	6.2k 1.3×	4.1k 2.0×	3.5k 1.8×	683 0.5×	2.4k 1.6×	435	12.6k

Countries citing papers authored by Lin Zhou

Since Specialization

Citations

This map shows the geographic impact of Lin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Zhou more than expected).

Fields of papers citing papers by Lin Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Zhou. The network helps show where Lin Zhou may publish in the future.

Co-authorship network of co-authors of Lin Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Zhou. A scholar is included among the top collaborators of Lin Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Zhou. Lin Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Lin, et al.. (2025). Ectopic thyroid tissue in the airway: a case report. BMC Pulmonary Medicine. 25(1). 46–46.

Zhao, Ziyi, et al.. (2025). Recent Advances in MXene-Based Electrochemical Sensors. Biosensors. 15(2). 107–107. 10 indexed citations

Zhou, Lin, et al.. (2025). Prenatal Characterization of Houge–Janssens Syndrome Type 2: A Case Report and Systematic Review of Fetal Phenotypes Associated With PPP2R1A Mutations. Molecular Genetics & Genomic Medicine. 13(8). e70129–e70129.

Hu, Minhua, Lin Zhou, Luyao Ma, et al.. (2024). Exploring genetic links between blood metabolites and gout susceptibility. Clinical Rheumatology. 43(12). 3901–3912. 1 indexed citations

Ding, Jun, Lingfeng Zhou, Dazhi Li, et al.. (2022). SMYD2 Promotes Hepatocellular Carcinoma Progression by Reprogramming Glutamine Metabolism via c-Myc/GLS1 Axis. Cells. 12(1). 25–25. 17 indexed citations

Wang, Wenchao, Zhengtao Liu, Junjie Qian, et al.. (2021). Systematic Assessment of Safety Threshold for Donor Age in Cadaveric Liver Transplantation. Frontiers in Medicine. 8. 596552–596552. 5 indexed citations

Zhou, Wei, Weiyang Lou, Junru Chen, et al.. (2021). AG-1024 Sensitizes Sorafenib-Resistant Hepatocellular Carcinoma Cells to Sorafenib via Enhancing G1/S Arrest. OncoTargets and Therapy. Volume 14. 1049–1059. 3 indexed citations

Huang, Jiacheng, Lele Zhang, Jianxiang Chen, et al.. (2021). The Landscape of Immune Cells Indicates Prognosis and Applicability of Checkpoint Therapy in Hepatocellular Carcinoma. Frontiers in Oncology. 11. 744951–744951. 12 indexed citations

Wei, Qiang, Kun Wang, Modan Yang, et al.. (2020). Recipient gender and body mass index are associated with early acute rejection in donation after cardiac death liver transplantation. Clinics and Research in Hepatology and Gastroenterology. 44. 100004–100004. 3 indexed citations

10.

Hu, Xiaoyi, Junjie Chen, Hechen Huang, et al.. (2020). Syndecan-4 promotes vascular beds formation in tissue engineered liver via thrombospondin 1. Bioengineered. 11(1). 1313–1324. 9 indexed citations

11.

Xu, Li, Shengjun Xu, Hangxiang Wang, et al.. (2018). Enhancing the Efficacy and Safety of Doxorubicin against Hepatocellular Carcinoma through a Modular Assembly Approach: The Combination of Polymeric Prodrug Design, Nanoparticle Encapsulation, and Cancer Cell-Specific Drug Targeting. ACS Applied Materials & Interfaces. 10(4). 3229–3240. 46 indexed citations

12.

Wang, Hangxiang, Zhongjie Lu, Lijiang Wang, et al.. (2017). New Generation Nanomedicines Constructed from Self-Assembling Small-Molecule Prodrugs Alleviate Cancer Drug Toxicity. Cancer Research. 77(24). 6963–6974. 133 indexed citations

13.

Zhang, Wu, Haiyang Xie, Songming Ding, et al.. (2016). CADM1 regelates the G1/S transition and represses tumorigenicity through the Rb-E2F pathway in hepatocellular carcinoma. Hepatobiliary & pancreatic diseases international. 15(3). 289–296. 21 indexed citations

14.

Lai, Ming-Chun, Wei Zhang, Wu Zhang, et al.. (2014). First case report of isolated penile mucormycosis in a liver transplantation recipient. International Journal of Infectious Diseases. 29. 208–210. 8 indexed citations

15.

Lin, Shengzhang, Kangjie Chen, Zhiyuan Xu, et al.. (2013). Prediction of Recurrence and Survival in Hepatocellular Carcinoma Based on Two Cox Models Mainly Determined by FoxP3+ Regulatory T Cells. Cancer Prevention Research. 6(6). 594–602. 41 indexed citations

16.

Ding, Songming, Wu Zhang, Zhiyuan Xu, et al.. (2013). Induction of an EMT-like transformation and MET in vitro. Journal of Translational Medicine. 11(1). 164–164. 18 indexed citations

17.

Xing, Chunyang, Wuhua Zhou, Songming Ding, et al.. (2012). Reversing Effect of Ring Finger Protein 43 Inhibition on Malignant Phenotypes of human Hepatocellular Carcinoma. Molecular Cancer Therapeutics. 12(1). 94–103. 23 indexed citations

18.

Jiang, Jianwen, et al.. (2011). Enteral supplementation with glycyl-glutamine improves intestinal barrier function after liver transplantation in rats. Hepatobiliary & pancreatic diseases international. 10(4). 380–385. 18 indexed citations

19.

Wu, Jian, Sunyi Ye, Xiaofeng Xu, et al.. (2011). Recipient Outcomes after ABO-Incompatible Liver Transplantation: A Systematic Review and Meta-Analysis. PLoS ONE. 6(1). e16521–e16521. 41 indexed citations

20.

Zhou, Lin, et al.. (2004). An ELISA method for determination of serum B lymphocyte stimulator levels and its clinical assessment. Academic Journal of Second Military Medical University. 25(12). 1317–1319. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact